Adam Woodrow Paratek Pharmaceuticals, Inc. (PRTK) insider trading activity

PRTK Quotes by TradingView

Adam Woodrow is President & Chief Commercial of Paratek Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of PRTK, which is worth approximately $0. The most recent transaction as insider was on Sep 21, 2023, when has been sold 749,034 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Adam Woodrow Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 21 2023
SELL
Sale (or disposition) back to the issuer
-
749,034 Reduced 100.0%
0 Common Stock
Aug 08 2023
BUY
Grant, award, or other acquisition
-
98,750 Added 11.63%
750,034 Common Stock
Dec 21 2022
SELL
Open market or private sale
$13,432 $1.99 p/Share
6,750 Reduced 1.03%
651,284 Common Stock
Dec 20 2022
BUY
Grant, award, or other acquisition
-
22,500 Added 3.31%
658,034 Common Stock
Dec 13 2022
SELL
Open market or private sale
$12,255 $1.96 p/Share
6,253 Reduced 0.97%
635,534 Common Stock
Dec 12 2022
SELL
Open market or private sale
$7,563 $1.98 p/Share
3,820 Reduced 0.59%
641,787 Common Stock
Oct 28 2022
SELL
Open market or private sale
$15,833 $3.47 p/Share
4,563 Reduced 0.7%
645,607 Common Stock
Oct 25 2022
BUY
Grant, award, or other acquisition
-
15,000 Added 2.26%
650,170 Common Stock
Aug 08 2022
BUY
Grant, award, or other acquisition
-
71,591 Added 10.13%
635,170 Common Stock
Mar 15 2022
BUY
Grant, award, or other acquisition
-
101,250 Added 15.23%
563,579 Common Stock
Dec 15 2021
SELL
Open market or private sale
$96,604 $4.27 p/Share
22,624 Reduced 4.67%
462,329 Common Stock
Dec 14 2021
SELL
Open market or private sale
$47,834 $4.37 p/Share
10,946 Reduced 2.21%
484,953 Common Stock
Dec 13 2021
SELL
Open market or private sale
$28,385 $4.42 p/Share
6,422 Reduced 1.28%
494,899 Common Stock
Aug 17 2021
SELL
Open market or private sale
$56,192 $5.12 p/Share
10,975 Reduced 2.14%
501,321 Common Stock
Aug 16 2021
BUY
Grant, award, or other acquisition
-
37,500 Added 6.82%
512,296 Common Stock
Jun 04 2021
SELL
Open market or private sale
$166,665 $9.7 p/Share
17,182 Reduced 3.49%
474,796 Common Stock
May 27 2021
BUY
Grant, award, or other acquisition
-
42,955 Added 8.03%
491,978 Common Stock
Mar 30 2021
BUY
Grant, award, or other acquisition
-
177,750 Added 28.36%
449,023 Common Stock
Dec 14 2020
SELL
Open market or private sale
$86,257 $6.71 p/Share
12,855 Reduced 4.52%
271,273 Common Stock
Dec 11 2020
SELL
Open market or private sale
$62,863 $6.95 p/Share
9,045 Reduced 3.09%
284,128 Common Stock
Nov 13 2020
SELL
Open market or private sale
$88,950 $5.93 p/Share
15,000 Reduced 4.87%
293,173 Common Stock
Nov 12 2020
BUY
Grant, award, or other acquisition
-
37,500 Added 10.85%
308,173 Common Stock
AW

Adam Woodrow

President & Chief Commercial
Boston, MA

Track Institutional and Insider Activities on PRTK

Follow Paratek Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRTK shares.

Notify only if

Insider Trading

Get notified when an Paratek Pharmaceuticals, Inc. insider buys or sells PRTK shares.

Notify only if

News

Receive news related to Paratek Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRTK